$53.11 -0.64 (%) Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Oct. 1, 2014 | 01:10 PM

Partner Headlines

  1. Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca

    Benzinga | Sep. 3, 2014 | 05:10AM EST
  2. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  3. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga | Aug. 15, 2014 | 07:23AM EST
  4. Jana Partners LLC Files its 13F

    Benzinga | Aug. 14, 2014 | 15:54PM EST
  5. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield

    Benzinga | Aug. 11, 2014 | 05:20AM EST
  6. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD | Aug. 7, 2014 | 12:04PM EST
  7. Did George Soros Sell His Stake In Israeli Based SodaStream Due To Political Reasons?

    Benzinga | Aug. 4, 2014 | 15:10PM EST
  8. 5 Drug Companies Profiting From Generics

    Benzinga | Aug. 4, 2014 | 08:29AM EST
  9. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD | Jul. 28, 2014 | 18:49PM EST
  10. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD | Jul. 28, 2014 | 13:02PM EST
  11. George Soros Reveals His Largest Stake

    GuruFocus | Jul. 23, 2014 | 19:06PM EST
  12. Sofinnova Ventures Closes $500M Fund

    FoxBusiness | Jul. 23, 2014 | 18:52PM EST
  13. Israel's Market Appears Unfazed By Rising Conflict

    IBD | Jul. 22, 2014 | 18:07PM EST
  14. George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR

    GuruFocus | Jul. 16, 2014 | 10:55AM EST
  15. UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

    Benzinga | Jul. 14, 2014 | 08:07AM EST
  16. 4 Top Performing Health Care Stocks With More Potential Upside

    Benzinga | Jul. 2, 2014 | 09:47AM EST
  17. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD | Jul. 1, 2014 | 17:19PM EST
  18. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield

    Benzinga | Jun. 27, 2014 | 05:44AM EST
  19. Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd

    GuruFocus | Jun. 26, 2014 | 15:14PM EST
  20. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus | Jun. 25, 2014 | 19:08PM EST
  21. Teva Pharmaceutical

    IBD | Jun. 20, 2014 | 18:38PM EST
  22. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD | Jun. 20, 2014 | 18:12PM EST
  23. Teva Turmoil: Shares Up, Board Trimmed, CEO To Retire

    Benzinga | Jun. 18, 2014 | 10:50AM EST
  24. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga | Jun. 11, 2014 | 11:36AM EST
  25. Top Guru Held Asian Companies of the First Quarter

    GuruFocus | Jun. 3, 2014 | 19:33PM EST
  26. Teva to buy Labrys Biologics

    IBD | Jun. 3, 2014 | 18:58PM EST
  27. Chicago sues painkiller firms

    IBD | Jun. 3, 2014 | 18:56PM EST
  28. Benzinga's M&A Chatter for Tuesday June 3, 2014

    Benzinga | Jun. 3, 2014 | 17:58PM EST
  29. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD | Jun. 3, 2014 | 11:57AM EST
  30. Richard Snow's Top Five Highlight Finance and Healthcare Sectors

    GuruFocus | May. 14, 2014 | 18:29PM EST
  31. Benzinga's M&A Chatter for Wednesday May 7, 2014

    Benzinga | May. 7, 2014 | 19:25PM EST
  32. ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga | May. 6, 2014 | 10:44AM EST
  33. Wrong Marketing Lesson by Big Pharma

    GuruFocus | May. 3, 2014 | 20:20PM EST
  34. Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries Ltd.

    Benzinga | May. 2, 2014 | 09:39AM EST
  35. Teva EPS tops; rivals seen?

    IBD | May. 1, 2014 | 18:54PM EST
  36. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga | May. 1, 2014 | 16:35PM EST
  37. Earnings Scheduled For May 1, 2014

    Benzinga | May. 1, 2014 | 05:36AM EST
  38. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD | Apr. 30, 2014 | 17:28PM EST
  39. Actavis Reporting Q1 Earnings Amid Merger Frenzy

    IBD | Apr. 29, 2014 | 15:33PM EST
  40. US Stock Futures Up Ahead Of Earnings, Consumer Confidence Data

    Benzinga | Apr. 29, 2014 | 07:29AM EST
  41. Morning Market Losers

    Benzinga | Apr. 28, 2014 | 09:51AM EST
  42. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 28, 2014 | 08:09AM EST
  43. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase III SYNERGY Trial for Combo with First-Line Docetaxel, Prednisone, Primary End Point Was Not Reached

    Benzinga | Apr. 28, 2014 | 07:21AM EST
  44. Nasdaq Could Be in for a Bounce

    FoxBusiness | Apr. 25, 2014 | 15:58PM EST
  45. Actavis got a Pfizer

    IBD | Apr. 24, 2014 | 18:36PM EST
  46. Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received Tenative FDA Approval for All Strengths; May Start Generic Versions in December

    Benzinga | Apr. 17, 2014 | 08:39AM EST
  47. Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing

    Benzinga | Apr. 16, 2014 | 15:18PM EST
  48. Teva Unveils Generic Lunesta Tablets in US

    Benzinga | Apr. 15, 2014 | 12:28PM EST
  49. Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the United States

    Benzinga | Apr. 8, 2014 | 08:46AM EST
  50. Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered Yet Again

    Benzinga | Apr. 7, 2014 | 16:41PM EST
Trading Center